#USA #Milwaukee #Rockwell Automation #Industrial Automation #PharmaSuite 12.00

Rockwell Automation Launches PharmaSuite 12.00

In a bold move towards enhancing the efficiency of the pharmaceutical and biopharmaceutical industries, Rockwell Automation has introduced its latest version of Manufacturing Execution System (MES), PharmaSuite 12.00. This new version promises to address crucial compliance needs while simplifying system management for manufacturers, allowing them to scale operations effectively. The announcement came during a press release on May 13, 2025, drawing attention from stakeholders across the industry.

Addressing Industry Challenges

The pharmaceutical sector is grappling with substantial demands for faster operations alongside the need for compliance with stringent regulatory requirements. As identified by BioPhorum, existing MES solutions often fall short, being perceived as costly and time-consuming to implement, lacking the flexibility necessary for contemporary operational demands. PharmaSuite 12.00 directly responds to these challenges by offering a simplified and configurable platform tailored for regulated manufacturing environments.

Key Features of PharmaSuite 12.00

The latest version introduces a modular architecture and comes equipped with new cloud capabilities enabling manufacturers to enjoy increased agility, allowing for a more dynamic response to production requirements. Key features of PharmaSuite 12.00 include:

1. Cloud-Based Deployment: The system now operates on Kubernetes using Linux containers, significantly speeding up both setup and maintenance processes.
2. Automated Setup Tool (MICKA): This innovative tool automates installation and validation steps, mitigating manual labor within regulated environments.
3. Modular Design: Containerized components facilitate cross-site scalability and standardization of deployments, allowing for a more cohesive operational strategy.
4. Integrated Monitoring: Centralized tools enhance early problem detection, significantly expediting troubleshooting.
5. Robust Cybersecurity: Designed with secure development practices, this version meets industry standards for compliance and data integrity.
6. Streamlined Upgrades: A new upgrade engine ensures that systems remain current with the latest features and security updates.

Supporting Digital Transformation

Martin Petrick, Business Manager for MES at Rockwell Automation, emphasized that PharmaSuite 12.00 is a pivotal advancement for life sciences manufacturers aiming to implement modular digital production processes while upholding the highest performance, availability, compliance, and security standards. The flexibility of cloud, on-premises, or hybrid deployments allows manufacturers to scale their operations more quickly, simplifying global rollouts and reducing both time and costs associated with validations.

Long-Standing Expertise

PharmaSuite 12.00 builds upon 15 years of continuous development and industry expertise, ensuring that Rockwell Automation continues to deliver a modern, compliant MES platform for the pharmaceutical and biopharmaceutical sectors. This release supports manufacturers in meeting their objectives related to scalable production and swift deployment, crucial in today's fast-paced market.

To learn more about FactoryTalk PharmaSuite, visit Rockwell Automation.

As industrial automation and digital transformation leaders, Rockwell Automation remains dedicated to enhancing productivity and sustainability through the innovative application of technology and human ingenuity. With approximately 27,000 employees serving customers across over 100 countries, their influence in the industry continues to grow, reinforcing their commitment to a Connected Enterprise approach that integrates technological advancements for superior operational benefits.